JPS643123A - Remedy for skin inflammation - Google Patents
Remedy for skin inflammationInfo
- Publication number
- JPS643123A JPS643123A JP15641587A JP15641587A JPS643123A JP S643123 A JPS643123 A JP S643123A JP 15641587 A JP15641587 A JP 15641587A JP 15641587 A JP15641587 A JP 15641587A JP S643123 A JPS643123 A JP S643123A
- Authority
- JP
- Japan
- Prior art keywords
- skin inflammation
- acetylsalicylic acid
- salt
- remedy
- active ingredient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
PURPOSE: To obtain a remedy for skin inflammation showing excellent effects on skin inflammation, especially on burn, containing at least one of acetylsalicylic acid or a salt thereof as an active ingredient.
CONSTITUTION: Acetylsalicylic acid or a salt thereof, preferably DL-lysine salt of acetylsalicylic acid as an active ingredient is pharmaceutically manufactured by a conventional procedure to give the aimed substance. The substance is usually administered as injection, percutaneously medicated in the case of skin inflammation, especially made into an aqueous solution and put as a wet compress on the affected part. In use, 1W10W/V%, preferably 2W5W/V% solution of the agent is administered for 30minW2hr per time and onceWseveral times daily.
COPYRIGHT: (C)1989,JPO&Japio
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62-156415A JPH013123A (en) | 1987-06-25 | Skin inflammation treatment agent |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62-156415A JPH013123A (en) | 1987-06-25 | Skin inflammation treatment agent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS643123A true JPS643123A (en) | 1989-01-06 |
| JPH013123A JPH013123A (en) | 1989-01-06 |
Family
ID=
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995015147A1 (en) * | 1993-12-02 | 1995-06-08 | Beiersdorf Ag | Use of l-arginine, l-ornithine or l-citrulline and topical preparations with these substances |
| WO2004030676A1 (en) * | 2002-09-30 | 2004-04-15 | Teikoku Seiyaku Co., Ltd. | External preparation for inhibiting keloid formation |
| US8658625B2 (en) | 2004-02-16 | 2014-02-25 | Teikoku Seiyaku Co., Ltd. | External preparation for treating painful skin wound |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995015147A1 (en) * | 1993-12-02 | 1995-06-08 | Beiersdorf Ag | Use of l-arginine, l-ornithine or l-citrulline and topical preparations with these substances |
| WO2004030676A1 (en) * | 2002-09-30 | 2004-04-15 | Teikoku Seiyaku Co., Ltd. | External preparation for inhibiting keloid formation |
| JP2004123551A (en) * | 2002-09-30 | 2004-04-22 | Teikoku Seiyaku Co Ltd | External preparation for suppressing formation of keloid or the like |
| US8658625B2 (en) | 2004-02-16 | 2014-02-25 | Teikoku Seiyaku Co., Ltd. | External preparation for treating painful skin wound |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX10086A (en) | A SYSTEM FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES NOT SOLUBLE IN WATER AND PROCEDURE FOR THEIR PREPARATION. | |
| IE871981L (en) | Programmed release formulation. | |
| JPS55153715A (en) | Prolonged granule of theophylline | |
| EP0724885A4 (en) | Pernasal composition and pernasal preparation containing the same | |
| IE791806L (en) | Gastroprotective mollusc extract | |
| ATE220321T1 (en) | ORAL DOSAGE FORMS CONTAINING SOLID FLUPIRTINE WITH CONTROLLED RELEASE OF ACTIVE INGREDIENTS | |
| ATE73656T1 (en) | ANTI-INFLAMMATORY MEDICATION CONTAINING IBUPROFEN WHICH IN AQUEOUS SOLUTION HAS NO BITTER TASTE, LARYNX IRRITATION AND INTESTINAL TOXICITY. | |
| KR910005858A (en) | Fatty acid therapy | |
| ES2052000T3 (en) | PROCEDURE FOR PREPARING PHARMACEUTICAL COMPOSITIONS CONTAINING PENTAMIDINE. | |
| IE791995L (en) | Formulation | |
| FI962056A0 (en) | New pharmaceutical composition for the manufacture of stable powder containing as active ingredient a combination of acetylsalicylic acid and methoclopramide | |
| IE894050L (en) | Compound with gastric acid inhibitory effect and process for¹its preparation | |
| WO2000026185A3 (en) | Omeprazole solution and method of using same | |
| EP0310126A3 (en) | Derivatives of pyrocatechol-carboxylic acid, their preparation and use as active ingredients in medicines | |
| JPS643123A (en) | Remedy for skin inflammation | |
| JPS5675423A (en) | Physiologically active high polymer substance-containing composition for mucosa administration and its preparation | |
| GR1002731B (en) | Medicinal solutions containing combinations of paracetamol and other active ingredients | |
| JPS56138110A (en) | Suppository containing citric acid or salt thereof | |
| MY101266A (en) | Pharmaceutical formulations | |
| JPS5326316A (en) | Drug containing active vitamin d3 derivatives and its preparation | |
| JPS57144214A (en) | Pharmaceutical preparation for rectum medication | |
| HK8994A (en) | Medicament for treatment of pregnancy-induced hypertension | |
| AU2001258859A1 (en) | Pralmorelin-containing nasal drop preparations | |
| JPS6429315A (en) | Drug for athlete's foot | |
| Nottage et al. | Effect of lithium on voluntary alcohol consumption by low and high preference mouse strains |